Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wal-Mart Discount Drug Program Casts Shadow Over Generic Supply Chain

Executive Summary

Wal-Mart's recent decision to offer a set, low price for a number of generic products could have significant negative business implications for the entire generic pharmaceutical supply chain

You may also be interested in...



Humana Walmart PDP May Drive Tougher Contracting By Retailers, Drug Plans

The new Medicare prescription drug plan being introduced jointly by Humana and Walmart for 2011 is dramatically less expensive than anything else in the Part D market and seems certain to prompt more intense scrutiny of drug costs among competing retailers and plans.

Humana Walmart PDP May Drive Tougher Contracting By Retailers, Drug Plans

The new Medicare prescription drug plan being introduced jointly by Humana and Walmart for 2011 is dramatically less expensive than anything else in the Part D market and seems certain to prompt more intense scrutiny of drug costs among competing retailers and plans.

Wal-Mart expands generics program

Wal-Mart is accelerating the roll-out of its discount generics program throughout Florida. The program, which was launched in the firm's Tampa-area outlets Sept. 21, provides 30-day supplies of certain generic products for $4 (1"The Pink Sheet" Oct. 2, 2006, p. 18). The firm had previously planned to launch the program statewide Jan. 1, 2007, but said it decided to advance the expansion due to strong demand. Wal-Mart reports 36,000 new prescriptions were filled in the Tampa stores in the first ten days after launch. Company also announces that the number of products included in the program has been expanded from 291 to 314...

Related Content

UsernamePublicRestriction

Register

OM009724

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel